<article article-type="article" specific-use="production" xml:lang="en" xmlns:hw="org.highwire.hpp" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:ref="http://schema.highwire.org/Reference" xmlns:hwp="http://schema.highwire.org/Journal" xmlns:l="http://schema.highwire.org/Linking" xmlns:r="http://schema.highwire.org/Revision" xmlns:x="http://www.w3.org/1999/xhtml" xmlns:app="http://www.w3.org/2007/app" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nlm="http://schema.highwire.org/NLM/Journal" xmlns:a="http://www.w3.org/2005/Atom" xmlns:c="http://schema.highwire.org/Compound" xmlns:hpp="http://schema.highwire.org/Publishing"><front><journal-meta><journal-id journal-id-type="hwp">biorxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title>bioRxiv</journal-title><abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title><publisher><publisher-name>Cold Spring Harbor Laboratory</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1101/225631</article-id><article-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;225631v1</article-id><article-id pub-id-type="other" hwp:sub-type="pisa-master">biorxiv;225631</article-id><article-id pub-id-type="other" hwp:sub-type="slug">225631</article-id><article-id pub-id-type="other" hwp:sub-type="tag">225631</article-id><article-version>1.1</article-version><article-categories><subj-group subj-group-type="author-type"><subject>Regular Article</subject></subj-group><subj-group subj-group-type="heading"><subject>New Results</subject></subj-group><subj-group subj-group-type="hwp-journal-coll" hwp:journal-coll-id="Bioinformatics" hwp:journal="biorxiv"><subject>Bioinformatics</subject></subj-group></article-categories><title-group><article-title hwp:id="article-title-1">Tumor-specific Causal Inference (TCI): A Bayesian Method for Identifying Causative Genome Alterations within Individual Tumors</article-title></title-group><contrib-group hwp:id="contrib-group-1"><contrib contrib-type="author" hwp:id="contrib-1"><name name-style="western" hwp:sortable="Cooper Gregory"><surname>Cooper</surname><given-names>Gregory</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-1" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-2"><name name-style="western" hwp:sortable="Cai Chunhui"><surname>Cai</surname><given-names>Chunhui</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-2" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-3"><name name-style="western" hwp:sortable="Lu Xinghua"><surname>Lu</surname><given-names>Xinghua</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-3" hwp:rel-id="aff-1">1</xref></contrib><aff id="a1" hwp:id="aff-1" hwp:rev-id="xref-aff-1-1 xref-aff-1-2 xref-aff-1-3"><label>1</label><institution hwp:id="institution-1">Department of Biomedical Informatics, School of Medicine, University of Pittsburgh</institution></aff></contrib-group><pub-date pub-type="epub-original" hwp:start="2017"><year>2017</year></pub-date><pub-date pub-type="hwp-created" hwp:start="2017-11-28T11:57:27-08:00">
    <day>28</day><month>11</month><year>2017</year>
  </pub-date><pub-date pub-type="hwp-received" hwp:start="2017-11-28T11:57:27-08:00">
    <day>28</day><month>11</month><year>2017</year>
  </pub-date><pub-date pub-type="epub" hwp:start="2017-11-28T12:03:00-08:00">
    <day>28</day><month>11</month><year>2017</year>
  </pub-date><pub-date pub-type="epub-version" hwp:start="2017-11-28T12:03:00-08:00">
    <day>28</day><month>11</month><year>2017</year>
  </pub-date><elocation-id>225631</elocation-id><history hwp:id="history-1">
<date date-type="received" hwp:start="2017-11-27"><day>27</day><month>11</month><year>2017</year></date>
<date date-type="rev-recd" hwp:start="2017-11-27"><day>27</day><month>11</month><year>2017</year></date>
<date date-type="accepted" hwp:start="2017-11-28"><day>28</day><month>11</month><year>2017</year></date>
</history><permissions><copyright-statement hwp:id="copyright-statement-1">© 2017, Posted by Cold Spring Harbor Laboratory</copyright-statement><copyright-year>2017</copyright-year><license hwp:id="license-1"><p hwp:id="p-1">The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.</p></license></permissions><self-uri xlink:href="225631.pdf" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/abstract" xlink:role="abstract" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:href="file:/content/biorxiv/vol0/issue2019/pdf/225631v1.pdf" hwp:variant="yes" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:role="full-text" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/source" xlink:role="source" content-type="xml" xlink:show="none" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/original" xlink:role="original" content-type="xml" xlink:show="none" hwp:variant="yes" xlink:href="225631.xml"/><self-uri content-type="abstract" xlink:href="file:/content/biorxiv/vol0/issue2019/abstracts/225631v1/225631v1.htslp"/><self-uri content-type="fulltext" xlink:href="file:/content/biorxiv/vol0/issue2019/fulltext/225631v1/225631v1.htslp"/><abstract hwp:id="abstract-1"><title hwp:id="title-1">Abstract</title><p hwp:id="p-2">Precision medicine for cancer involves identifying and targeting the somatic genome alterations (SGAs) that drive the development of an individual tumor. Much of current efforts at finding driver SGAs have involved identifying the genes that are mutated more frequently than expected among a collection of tumors. When these population-derived driver genes are altered (perhaps in particular ways) in a given tumor, they are posited as driver genes for that tumor. In this technical report, we introduce an alternative approach for identifying causative SGAs, also known as “drivers”, by inferring causal relationships between SGAs and molecular phenotypes at the individual tumor level. Our tumor-specific causal inference (TCI) algorithm uses a Bayesian method to identify the SGAs in a given tumor that have a high probability of regulating transcriptomic changes observed in that specific tumor. Thus, the method is focused on identifying the tumor specific SGAs that are causing expression changes that are specific to the tumor. Those SGAs that have a high probability of regulating transcriptomic changes related to oncogenic processes are then designated to be the putative drivers of the tumor. In this paper, we describe in detail the TCI algorithm and its implementation.</p></abstract><counts><page-count count="17"/></counts><custom-meta-wrap>
    <custom-meta hwp:id="custom-meta-1">
      <meta-name>has-earlier-version</meta-name>
      <meta-value>yes</meta-value>
    </custom-meta>
  </custom-meta-wrap></article-meta></front><body><sec id="s1" hwp:id="sec-1"><label>1.</label><title hwp:id="title-2">Introduction</title><p hwp:id="p-3">Cancer is mainly caused by SGAs, such as somatic mutations (SMs), somatic copy number alterations (SCNAs), chromosome rearrangement and other genomic alterations. A tumor cell commonly hosts hundreds to over a thousand SGAs, among which only a small minority contribute to tumor development by perturbing cellular signaling pathways while most others are passenger SGAs (unrelated to cancers). A foremost task of precision oncology for cancer treatment is to identify and target the driver SGAs of an individual tumor. Current methods of identifying candidate driver SGAs are mostly based on the assumption that, if a gene is mutated at a frequency significantly above the expected rate in a cohort of tumors, the mutation events of the gene are likely positively selected in tumors due to resultant oncogenic advantages. Therefore, such a gene is more likely a cancer driver gene [<xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-1" hwp:rel-id="ref-1">1</xref>–<xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-1" hwp:rel-id="ref-4">4</xref>]. Hereafter, we refer to this family of methods as <italic toggle="yes">frequency-oriented models</italic>. These models do not attempt to explicitly determine the functional role of a driver in cancer development, that is, they cannot provide insight into functional impact of oncogenic processes caused by a driver SGA. In general, frequency-oriented models are constrained by the need to define the baseline mutation rate, and different models for estimating the baseline rate will lead to different results.</p><p hwp:id="p-4">It is well accepted that driver genes can contribute to cancer development through various types of genomic alterations, such as chromosome structure variations, non-coding mutations, and epigenetic modifications [<xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-1" hwp:rel-id="ref-3">3</xref>, <xref ref-type="bibr" rid="c5" hwp:id="xref-ref-5-1" hwp:rel-id="ref-5">5</xref>–<xref ref-type="bibr" rid="c7" hwp:id="xref-ref-7-1" hwp:rel-id="ref-7">7</xref>]. For example, copy number amplification and promoter mutations of the telomere reverse transcriptase (<italic toggle="yes">TERT</italic>) play important roles in different cancer types [<xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-1" hwp:rel-id="ref-8">8</xref>, <xref ref-type="bibr" rid="c9" hwp:id="xref-ref-9-1" hwp:rel-id="ref-9">9</xref>]. However, to our knowledge, there is no reported principled method to integrate multiple types of SGA events to determine the significance of the corresponding gene in cancer development, nor there is any theoretical method that can systematically infer the functional impact of driver SGAs perturbing a common gene.</p><p hwp:id="p-5">Here, we introduce a novel framework that identifies driver SGAs in a tumor-specific and signal-oriented fashion. Our approach is based on the assumption that driver SGAs cause cancer progression by perturbing signaling pathways, and as such their functional impact is reflected by the cellular or molecular phenotypes regulated by these perturbed pathways. Thus, the task is to find the SGAs that causally regulate cancer-related molecular phenotypes, e.g., differential expression of genes involved in oncogenic processes, for each individual tumor. To this end, we designed a tumor-specific causal inference (TCI) algorithm that infers causal relationships between SGAs and differentially expressed genes (DEGs) within a specific tumor.</p><p hwp:id="p-6">The Bayesian causal inference framework developed in this study provides a principled approach to not only incorporate biological prior knowledge and theoretical assumptions but also integrate diverse types of genomic and molecular phenotypic data to infer the functional impact of genomic alterations in individual tumors [<xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-1" hwp:rel-id="ref-10">10</xref>, <xref ref-type="bibr" rid="c11" hwp:id="xref-ref-11-1" hwp:rel-id="ref-11">11</xref>]. In these respects, TCI first calculates the prior probability that an SGA is a driver in the tumor of interest. Based on the positive selection assumption underlying the frequency-based methods, we assume that the more often are the SGA events perturbing the corresponding gene in a tumor cohort, the more likely the gene is a driver in the current tumor. As such, the calculation of the prior incorporates the strength of the frequency-oriented methods [<xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-2" hwp:rel-id="ref-1">1</xref>, <xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-2" hwp:rel-id="ref-3">3</xref>]. In a signal-oriented fashion, TCI further calculates the marginal likelihood that the molecular phenotype change is caused by the SGA. Finally, TCI derives a posterior probability that the SGA is causally responsible for the observed phenotypic change in a tumor. Thus, TCI unifies the frequency-oriented and signal-oriented approaches to determine the functional impact of an SGA event within a specific tumor.</p><p hwp:id="p-7">Previously reported approaches, e.g. eQTL, can infer the association between SGAs and gene expression levels across a population of tumors [<xref ref-type="bibr" rid="c12" hwp:id="xref-ref-12-1" hwp:rel-id="ref-12">12</xref>, <xref ref-type="bibr" rid="c13" hwp:id="xref-ref-13-1" hwp:rel-id="ref-13">13</xref>]. To our knowledge, however, no previously published method is capable of inferring the causal relationships between SGAs and differentially expressed genes (DEGs) in a tumor-specific manner. In this paper, we introduce such an approach which is tumor specific in two ways. First, for a given DEG <italic toggle="yes">E</italic> in a given tumor t, the only SGAs that can possibly cause (drive) <italic toggle="yes">E</italic> are the SGAs in t; SGAs that occur in other tumors, but not in t, are not candidate drivers of <italic toggle="yes">E</italic> in t. Thus, the search space for candidate drivers is focused in a tumor-specific manner. Second, the scoring of a given SGA in <italic toggle="yes">t</italic> being a driver of <italic toggle="yes">E</italic> is scored probabilistically in manner that is tumor-specific, as we explain in <xref ref-type="sec" rid="s2b" hwp:id="xref-sec-4-1" hwp:rel-id="sec-4">Section 2.2</xref>.</p><p hwp:id="p-8">The change in going from population-based to tumor-specific causal inference is substantial. Since multiple SGAs can perturb a common signaling pathway, we should consider the causal relationships between SGAs perturbing the pathway and a DEG regulated by the pathway as a multiple-to-one relationship. For example, multiple perturbations of the PI3K pathway are known to regulate its downstream gene expression during tumorigenesis [<xref ref-type="bibr" rid="c14" hwp:id="xref-ref-14-1" hwp:rel-id="ref-14">14</xref>]. Interestingly, rarely do SGAs perturb a common pathway in an individual tumor, which is a phenomenon referred to as mutual exclusivity [<xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-1" hwp:rel-id="ref-15">15</xref>–<xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-1" hwp:rel-id="ref-19">19</xref>]. <xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-1" hwp:rel-id="F1">Figure 1</xref> illustrates the mutual exclusive tendency among 3 members of the PI3K pathway, <italic toggle="yes">PIK3CA, PTEN</italic>, and <italic toggle="yes">PIK3R1</italic> [<xref ref-type="bibr" rid="c14" hwp:id="xref-ref-14-2" hwp:rel-id="ref-14">14</xref>]. At the tumor population level, any SGA perturbing the PI3K pathway can cause the expression change of a downstream gene, while in an individual tumor, it is more likely that only one SGA causes the expression change. The multiple-to-one relationship and the mutual exclusivity of the SGAs significantly dampens the strength of statistical association between an individual SGA and the DEG of interest when viewed across all tumors (perhaps of a given type). Therefore, a conventional EQTL analysis may fail to find the causal relationship between a low frequency SGA (e.g., <italic toggle="yes">PIK3R1)</italic> that is perturbing a downstream gene via the PI3K pathway, because it cannot adequately account for the gene expression variance caused by other common SGAs that are perturbing the gene in other tumors (e.g., mutation/amplification of <italic toggle="yes">PIK3CA</italic> and mutation/deletion of <italic toggle="yes">PTEN)</italic>. Although at the population level it may not be significantly (statistically) associated with a DEG <italic toggle="yes">E</italic> that is downstream of the PI3K pathway, an alteration of <italic toggle="yes">PIK3R1</italic> should nonetheless be the most probable cause of <italic toggle="yes">E</italic> in an individual tumor when both <italic toggle="yes">PIK3CA</italic> and <italic toggle="yes">PTEN</italic> are normal. The TCI algorithm takes advantage of such tumor-specific relationships between SGAs and DEGs in order to locate the SGAs that are most likely driving the DEGs.</p><fig id="fig1" position="float" orientation="portrait" fig-type="figure" hwp:id="F1" hwp:rev-id="xref-fig-1-1 xref-fig-1-2 xref-fig-1-3"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;225631v1/FIG1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F1</object-id><object-id pub-id-type="publisher-id">fig1</object-id><label>Figure 1.</label><caption hwp:id="caption-1"><title hwp:id="title-3">SGAs mutual exclusivity among <italic toggle="yes">PIK3CA, PTEN</italic>, and <italic toggle="yes">PIK3R1</italic> in the PI3K pathway.</title><p hwp:id="p-9">An example of mutual exclusivity among <italic toggle="yes">PIK3CA, PTEN</italic>, and <italic toggle="yes">PIK3R1</italic> affecting the PI3K pathway in 273 Glioblastoma Multiforme tumor samples. Each column represents an individual tumor. The combination of color and bar size denotes genetic alteration types: a long red bar represents a tumor with copy number amplification; a long blue bar represents a tumor with copy number deletion; a short green bar represents a tumor with missense mutation; a short brown bar represents a tumor with inframe mutation; a short black bar represents a tumor with truncating mutation. These three SGAs are altered in 156 (57%) out of 273 brain tumors, and as shown, only one of those SGAs occurs in most of the tumors.</p></caption><graphic xlink:href="225631_fig1" position="float" orientation="portrait" hwp:id="graphic-1"/></fig></sec><sec id="s2" hwp:id="sec-2"><label>2.</label><title hwp:id="title-4">Model Specification</title><p hwp:id="p-10">Let the genotypes of all genes in a tumor be represented by a set of binary variables, such that the state of a gene is set to 1 if the gene is altered (e.g., mutated), or otherwise it is set to 0; similarly, let the expression states of all genes be represented by a set of binary variables, such that the expression state of a gene is set to 1 if it is differentially expressed, or otherwise it is set to 0. Let <bold>TS</bold> = {<italic toggle="yes">T<sub>1</sub>, T<sub>2</sub>, …, T<sub>t</sub>, …, T<sub>N</sub></italic>} denote the tumor set which contains a total <italic toggle="yes">N</italic> tumor samples, where <italic toggle="yes">t</italic> indexes over the tumors included in the tumor set. Let <bold>SGA</bold><sub><italic toggle="yes">t</italic></sub> = {<italic toggle="yes">A<sub>1</sub>, A<sub>2</sub>,…, A<sub>h</sub>,…, A<sub>m</sub></italic>} denote a subset of <italic toggle="yes">m</italic> genes that are altered at the genome level in a tumor <italic toggle="yes">t</italic>, i.e., their genomic states are set to 1, where <italic toggle="yes">h</italic> indexes over the variables in <bold>SGA</bold><sub><italic toggle="yes">t</italic></sub>; let <bold>DEG</bold><sub><italic toggle="yes">t</italic></sub> = {<italic toggle="yes">E<sub>1</sub>, E<sub>2</sub>, …, E<sub>i</sub>, …, E<sub>n</sub></italic>} denote <italic toggle="yes">n</italic> genes that are differentially expressed in the tumor <italic toggle="yes">t</italic>, where <italic toggle="yes">i</italic> indexes over the variables in <bold>DEG</bold><sub><italic toggle="yes">t</italic></sub>. Hereafter, we will use SGA instead of <bold>SGA</bold><sub><italic toggle="yes">t</italic></sub> and DEG instead of <bold>DEG</bold><sub><italic toggle="yes">t</italic></sub> for simplicity of notation. For each tumor, we further include a variable <italic toggle="yes">A</italic><sub>0</sub>, to collectively represent non-specific factors other than SGAs (e.g., tumor microenvironment) that may affect the gene expression in a tumor. Based on the assumptions that each DEG is likely to be regulated by one aberrant signaling pathway and such a pathway is likely perturbed by only one SGA observed in the tumor (mutual exclusivity), the TCI model further constrains each DEG to be causally regulated by only one SGA (or by <italic toggle="yes">A<sub>0</sub></italic>) in a given tumor. The TCI model assumes no hidden common causes among the variables in <bold>SGA</bold>∪<bold>DEG</bold>, including the presence of mixture distributions. It is not concerned with modeling the causal relationships among the variables within <bold>DEG</bold> or among the variables within <bold>SGA</bold>. With the above settings, the task is to determine for each variable <italic toggle="yes">A<sub>h</sub></italic> in <bold>SGA</bold> the probability that it is the cause of one or more variables in <bold>DEG</bold>, which we interpret as the probability that <italic toggle="yes">A<sub>h</sub></italic> is a driver in tumor <italic toggle="yes">t</italic>.</p><p hwp:id="p-11">For a given tumor, we represent the causal relationships between the variables in <bold>SGA</bold> and those in <bold>DEG</bold> using a bipartite causal Bayesian network (CBN) in which the variables in <bold>SGA</bold> are at level 1 and the variables in <bold>DEG</bold> are at level 2. In such a CBN, arcs always point from <bold>SGA</bold> to <bold>DEG</bold>. A permissible CBN model <italic toggle="yes">M</italic> has only one arc coming into each variable <italic toggle="yes">E<sub>i</sub></italic> in DEG from one variable <italic toggle="yes">A<sub>h</sub></italic> in SGA or <italic toggle="yes">A<sub>0</sub></italic> which means that it is abnormal due to some non-SGA influence. In model <italic toggle="yes">M</italic>, a given <italic toggle="yes">A<sub>h</sub></italic> can have zero arcs (a passenger SGA) or one or more arcs emanating from it to the variables in <bold>DEG</bold>; thus, an SGA can causally regulate multiple DEGs. <xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-1" hwp:rel-id="F2">Figure 2</xref> shows an example of a permissible model. Since each tumor generally has a unique <bold>SGA</bold> set and a unique <bold>DEG</bold> set, the model is called tumor-specific.</p><fig id="fig2" position="float" orientation="portrait" fig-type="figure" hwp:id="F2" hwp:rev-id="xref-fig-2-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;225631v1/FIG2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F2</object-id><object-id pub-id-type="publisher-id">fig2</object-id><label>Figure 2.</label><caption hwp:id="caption-2"><title hwp:id="title-5">Tumor-specific Bayesian causal inference framework.</title><p hwp:id="p-12">An example of an admissible CBN for inferring causal relationships between SGAs and DEGs. Here, each plate represents one tumor. For the tumor <italic toggle="yes">T<sub>1</sub></italic>, set SGA has three SGA variables plus the non-specific factor <italic toggle="yes">A<sub>0</sub></italic> (m = 4) and set <bold>DEG</bold> has six DEG variables (n = 6). Each <italic toggle="yes">E<sub>i</sub></italic> must have exactly one arc into it, which represents having one cause among the variables in set <bold>SGA</bold>. In this model, <italic toggle="yes">E<sub>1</sub></italic> is caused by <italic toggle="yes">A<sub>0</sub></italic>, and <italic toggle="yes">A<sub>1</sub></italic> and <italic toggle="yes">A<sub>3</sub></italic> are drivers of DEGs ({<italic toggle="yes">E</italic><sub>2</sub>, <italic toggle="yes">E</italic><sub>3</sub>, <italic toggle="yes">E</italic><sub>4</sub>} and {<italic toggle="yes">E<sub>5</sub>, E<sub>6</sub></italic>} respectively), while <italic toggle="yes">A<sub>2</sub></italic> is not a driver.</p></caption><graphic xlink:href="225631_fig2" position="float" orientation="portrait" hwp:id="graphic-2"/></fig><sec id="s2a" hwp:id="sec-3" hwp:rev-id="xref-sec-3-1"><label>2.1.</label><title hwp:id="title-6">The basic Bayesian framework of the TCI model</title><p hwp:id="p-13">Let <italic toggle="yes">M</italic> be a CBN structure and let <italic toggle="yes">D</italic> be an observational training dataset, in which each case denotes a sample that contains a measurement for each of the variables in <italic toggle="yes">M</italic>. We assume that the cases in <italic toggle="yes">D</italic> are i.i.d..</p><p hwp:id="p-14">We can derive the posterior probability of a CBN structure <italic toggle="yes">M</italic> as follows:
<disp-formula id="eqn1" hwp:id="disp-formula-1" hwp:rev-id="xref-disp-formula-1-1">
<alternatives hwp:id="alternatives-1"><graphic xlink:href="225631_eqn1.gif" position="float" orientation="portrait" hwp:id="graphic-3"/></alternatives>
</disp-formula>
where the sum is taken over all admissible models <italic toggle="yes">M’</italic>. The term <italic toggle="yes">P</italic>(<italic toggle="yes">M</italic>) denotes prior belief that the data-generating CBN has <italic toggle="yes">M</italic> as its structure.</p><p hwp:id="p-15">We call the term <italic toggle="yes">P</italic>(<italic toggle="yes">D, M</italic>) the score of CBN structure <italic toggle="yes">M</italic> in light of data <italic toggle="yes">D</italic>. As shown in <xref ref-type="disp-formula" rid="eqn1" hwp:id="xref-disp-formula-1-1" hwp:rel-id="disp-formula-1">Equation 1</xref>, it can be expressed as follows:
<disp-formula id="eqn2" hwp:id="disp-formula-2" hwp:rev-id="xref-disp-formula-2-1">
<alternatives hwp:id="alternatives-2"><graphic xlink:href="225631_eqn2.gif" position="float" orientation="portrait" hwp:id="graphic-4"/></alternatives>
</disp-formula></p><p hwp:id="p-16">We will assume that <italic toggle="yes">P</italic>(<italic toggle="yes">M</italic>) is a modular prior probability that can be expressed as follows:
<disp-formula id="eqn3" hwp:id="disp-formula-3" hwp:rev-id="xref-disp-formula-3-1">
<alternatives hwp:id="alternatives-3"><graphic xlink:href="225631_eqn3.gif" position="float" orientation="portrait" hwp:id="graphic-5"/></alternatives>
</disp-formula>
where <italic toggle="yes">A</italic><sub><italic toggle="yes">g</italic>(<italic toggle="yes">i</italic>)</sub> is a node in <bold>SGA</bold> that is the parent of <italic toggle="yes">E<sub>i</sub></italic> in <italic toggle="yes">M</italic>, and <italic toggle="yes">P</italic>(<italic toggle="yes">A</italic><sub><italic toggle="yes">g</italic>(<italic toggle="yes">i</italic>)</sub>-&gt;<italic toggle="yes">E<sub>i</sub></italic>) is the prior probability that <italic toggle="yes">A</italic><sub><italic toggle="yes">g</italic>(<italic toggle="yes">i</italic>)</sub> is causally influencing <italic toggle="yes">E<sub>i</sub></italic> in the current tumor. The function <italic toggle="yes">g</italic>(<italic toggle="yes">i</italic>) returns an index of <italic toggle="yes">A</italic>. If <italic toggle="yes">g</italic>(<italic toggle="yes">i</italic>) = 0 then <italic toggle="yes">A<sub>0</sub></italic> represents its parent, which means <italic toggle="yes">E<sub>i</sub></italic> is regulated by a non-SGA factor in the tumor.</p><p hwp:id="p-17">The term <italic toggle="yes">P</italic>(<italic toggle="yes">D</italic>|<italic toggle="yes">M</italic>) is the marginal likelihood of <italic toggle="yes">M</italic>, which can be derived by marginalizing out model parameters <italic toggle="yes">θ</italic> as follows:
<disp-formula id="eqn4" hwp:id="disp-formula-4" hwp:rev-id="xref-disp-formula-4-1">
<alternatives hwp:id="alternatives-4"><graphic xlink:href="225631_eqn4.gif" position="float" orientation="portrait" hwp:id="graphic-6"/></alternatives>
</disp-formula>
where <italic toggle="yes">θ</italic> represents the parameters (probabilities) associated with CBN structure <italic toggle="yes">M</italic>.</p><p hwp:id="p-18">If we assume parameter independence, parameter modularity, and Dirichlet prior probability distributions, we can solve <xref ref-type="disp-formula" rid="eqn4" hwp:id="xref-disp-formula-4-1" hwp:rel-id="disp-formula-4">Equation 4</xref> to derive <italic toggle="yes">P</italic>(<italic toggle="yes">D</italic>|<italic toggle="yes">M</italic>) in closed form[<xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-1" hwp:rel-id="ref-20">20</xref>] as follows:
<disp-formula id="eqn5" hwp:id="disp-formula-5" hwp:rev-id="xref-disp-formula-5-1">
<alternatives hwp:id="alternatives-5"><graphic xlink:href="225631_eqn5.gif" position="float" orientation="portrait" hwp:id="graphic-7"/></alternatives>
</disp-formula>
where:
<list list-type="bullet" hwp:id="list-1"><list-item hwp:id="list-item-1"><p hwp:id="p-19"><italic toggle="yes">i</italic> indexes over the DEG variables included in <italic toggle="yes">M</italic>;</p></list-item><list-item hwp:id="list-item-2"><p hwp:id="p-20"><italic toggle="yes">n</italic> is the number of DEGs in <italic toggle="yes">M</italic>, i.e., the nodes in the <bold>DEG</bold> set of <italic toggle="yes">M</italic>;</p></list-item><list-item hwp:id="list-item-3"><p hwp:id="p-21"><italic toggle="yes">j</italic> indexes over the 0/1 values (states) of a gene <italic toggle="yes">A</italic> in <bold>SGA</bold> that is being modeled as the parent of <italic toggle="yes">E<sub>i</sub></italic> in <italic toggle="yes">M</italic>;</p></list-item><list-item hwp:id="list-item-4"><p hwp:id="p-22"><italic toggle="yes">q<sub>i</sub></italic> is the number of values of parent gene <italic toggle="yes">A</italic> of the node <italic toggle="yes">E<sub>i</sub></italic>, which is 2, because the <italic toggle="yes">A</italic> is modeled as having the values 1 (a somatic genome alteration) and 0 (no alteration);</p></list-item><list-item hwp:id="list-item-5"><p hwp:id="p-23"><italic toggle="yes">k</italic> indexes over the 0/1 values of the expression states of <italic toggle="yes">E<sub>i</sub></italic>;</p></list-item><list-item hwp:id="list-item-6"><p hwp:id="p-24"><italic toggle="yes">r<sub>i</sub></italic> is the number of values of node <italic toggle="yes">E<sub>i</sub></italic>, which is 2, because <italic toggle="yes">E</italic> is modeled as having the values 1 (a differential gene expression level) and 0 (a normal level of gene expression);</p></list-item><list-item hwp:id="list-item-7"><p hwp:id="p-25"><italic toggle="yes">N<sub>ijk</sub></italic> is the number of cases in <italic toggle="yes">D</italic> that node <italic toggle="yes">E<sub>i</sub></italic> has the value denoted by <italic toggle="yes">k</italic> and its parent has the value denoted by <italic toggle="yes">j</italic>;</p></list-item><list-item hwp:id="list-item-8"><p hwp:id="p-26"><italic toggle="yes">α<sub>ijk</sub></italic> is a parameter in a Dirichlet distribution that represents prior belief about <italic toggle="yes">P(E<sub>i</sub></italic> | <italic toggle="yes">parent(E<sub>i</sub>))</italic>; it can be interpreted as belief equivalent to having previously seen (prior to data <italic toggle="yes">D</italic>) <italic toggle="yes">a<sub>ijk</sub></italic> cases in which node <italic toggle="yes">E<sub>i</sub></italic> has the value <italic toggle="yes">k</italic> and its parent has the value <italic toggle="yes">j</italic>;</p></list-item><list-item hwp:id="list-item-9"><p hwp:id="p-27">Γ is the gamma function;</p></list-item><list-item hwp:id="list-item-10"><p hwp:id="p-28"><inline-formula hwp:id="inline-formula-1"><alternatives hwp:id="alternatives-6"><inline-graphic xlink:href="225631_inline1.gif" hwp:id="inline-graphic-1"/></alternatives></inline-formula></p></list-item><list-item hwp:id="list-item-11"><p hwp:id="p-29"><inline-formula hwp:id="inline-formula-2"><alternatives hwp:id="alternatives-7"><inline-graphic xlink:href="225631_inline2.gif" hwp:id="inline-graphic-2"/></alternatives></inline-formula></p></list-item></list></p><p hwp:id="p-30">Substituting <xref ref-type="disp-formula" rid="eqn3" hwp:id="xref-disp-formula-3-1" hwp:rel-id="disp-formula-3">Equations 3</xref> and <xref ref-type="disp-formula" rid="eqn5" hwp:id="xref-disp-formula-5-1" hwp:rel-id="disp-formula-5">5</xref> into <xref ref-type="disp-formula" rid="eqn2" hwp:id="xref-disp-formula-2-1" hwp:rel-id="disp-formula-2">Equation 2</xref> yields:
<disp-formula id="eqn6" hwp:id="disp-formula-6" hwp:rev-id="xref-disp-formula-6-1 xref-disp-formula-6-2">
<alternatives hwp:id="alternatives-8"><graphic xlink:href="225631_eqn6.gif" position="float" orientation="portrait" hwp:id="graphic-8"/></alternatives>
</disp-formula></p><p hwp:id="p-31">Let <italic toggle="yes">e</italic>(<italic toggle="yes">g</italic>(<italic toggle="yes">i</italic>), <italic toggle="yes">i</italic>) represent the function that appears inside the outer product of <xref ref-type="disp-formula" rid="eqn6" hwp:id="xref-disp-formula-6-1" hwp:rel-id="disp-formula-6">Equation 6</xref>. Thus, it is defined as follows:
<disp-formula id="eqn7" hwp:id="disp-formula-7" hwp:rev-id="xref-disp-formula-7-1 xref-disp-formula-7-2">
<alternatives hwp:id="alternatives-9"><graphic xlink:href="225631_eqn7.gif" position="float" orientation="portrait" hwp:id="graphic-9"/></alternatives>
</disp-formula></p><p hwp:id="p-32">We can now write <xref ref-type="disp-formula" rid="eqn6" hwp:id="xref-disp-formula-6-2" hwp:rel-id="disp-formula-6">Equation 6</xref> as follows:
<disp-formula id="eqn8" hwp:id="disp-formula-8" hwp:rev-id="xref-disp-formula-8-1">
<alternatives hwp:id="alternatives-10"><graphic xlink:href="225631_eqn8.gif" position="float" orientation="portrait" hwp:id="graphic-10"/></alternatives>
</disp-formula></p><p hwp:id="p-33"><xref ref-type="disp-formula" rid="eqn7" hwp:id="xref-disp-formula-7-1" hwp:rel-id="disp-formula-7">Equation 7</xref> is the score for a causal arc existing from <italic toggle="yes">A</italic><sub><italic toggle="yes">g</italic>(<italic toggle="yes">i</italic>)</sub> to <italic toggle="yes">E<sub>i</sub></italic>. However, we wish to have a nonzero score only for a causal relationship that satisfies the following constraint: <italic toggle="yes">E<sub>i</sub></italic> is more likely to be abnormal (value 1) when <italic toggle="yes">A</italic><sub><italic toggle="yes">g</italic>(<italic toggle="yes">i</italic>)</sub> is abnormal (value 1) than when <italic toggle="yes">A</italic><sub><italic toggle="yes">g</italic>(<italic toggle="yes">i</italic>)</sub> is normal (value 0). Given the Dirichlet distributions we are using, the expectation of these conditional probabilities is as follows:
<disp-formula id="eqn9" hwp:id="disp-formula-9">
<alternatives hwp:id="alternatives-11"><graphic xlink:href="225631_eqn9.gif" position="float" orientation="portrait" hwp:id="graphic-11"/></alternatives>
</disp-formula></p><p hwp:id="p-34">Using conditional probabilities of this form to enforce the constraint mentioned above, leads to the following function:
<disp-formula id="eqn10" hwp:id="disp-formula-10" hwp:rev-id="xref-disp-formula-10-1 xref-disp-formula-10-2">
<alternatives hwp:id="alternatives-12"><graphic xlink:href="225631_eqn10.gif" position="float" orientation="portrait" hwp:id="graphic-12"/></alternatives>
</disp-formula></p><p hwp:id="p-35">We next use <italic toggle="yes">f</italic> to refine <xref ref-type="disp-formula" rid="eqn8" hwp:id="xref-disp-formula-8-1" hwp:rel-id="disp-formula-8">Equation 8</xref> to be the following:
<disp-formula id="eqn11" hwp:id="disp-formula-11">
<alternatives hwp:id="alternatives-13"><graphic xlink:href="225631_eqn11.gif" position="float" orientation="portrait" hwp:id="graphic-13"/></alternatives>
</disp-formula></p><p hwp:id="p-36">The posterior probability that an SGA <italic toggle="yes">A<sub>h</sub></italic> causes a DEG <italic toggle="yes">E<sub>i</sub></italic> in tumor <italic toggle="yes">t</italic> relative to the <bold>SGA</bold> and <bold>DEG</bold> is calculated as follows,
<disp-formula id="eqn12" hwp:id="disp-formula-12" hwp:rev-id="xref-disp-formula-12-1">
<alternatives hwp:id="alternatives-14"><graphic xlink:href="225631_eqn12.gif" position="float" orientation="portrait" hwp:id="graphic-14"/></alternatives>
</disp-formula></p></sec><sec id="s2b" hwp:id="sec-4" hwp:rev-id="xref-sec-4-1"><label>2.2.</label><title hwp:id="title-7">Tumor-centric scoring</title><p hwp:id="p-37">When assessing the causal relationship between <italic toggle="yes">A<sub>h</sub></italic> and <italic toggle="yes">E<sub>i</sub></italic> using <xref ref-type="disp-formula" rid="eqn12" hwp:id="xref-disp-formula-12-1" hwp:rel-id="disp-formula-12">Equation 12</xref>, we consider the states of <italic toggle="yes">A<sub>h</sub></italic> and <italic toggle="yes">E<sub>i</sub></italic> in all tumors in the training set. As mentioned previously, however, <italic toggle="yes">E<sub>i</sub></italic> could be regulated by multiple distinct SGAs that affect a common signaling pathway. These SGAs tend to be mutually exclusive across all tumors. For example, a gene that is expressed downstream in the PI3K pathway would be differentially expressed in tumors hosting either a <italic toggle="yes">PTEN</italic> deletion/mutation or a <italic toggle="yes">PIK3CA</italic> amplification/mutations, and these two SGA events tend to be mutually exclusive (<xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-2" hwp:rel-id="F1">Figure 1</xref>). Under such circumstances, either a <italic toggle="yes">PTEN</italic> alteration or a <italic toggle="yes">PIK3CA</italic> alteration should be sufficient to explain DEG <italic toggle="yes">E<sub>PI3K</sub></italic>.</p><p hwp:id="p-38">In this section, we describe a modified Bayesian scoring measure that models SGAs affecting a DEG. Consider the situation in which <italic toggle="yes">A<sup>*</sup></italic> is the driver of DEG <italic toggle="yes">E<sub>i</sub></italic> in most tumors. Suppose a tumor <italic toggle="yes">t</italic> that is currently being analyzed has <italic toggle="yes">E<sub>i</sub></italic> as a DEG but does not include <italic toggle="yes">A<sup>*</sup></italic> as an SGA. In this case, we need to locate the SGA that is most likely the driver of <italic toggle="yes">E<sub>i</sub></italic> in tumor <italic toggle="yes">t</italic>, in light of most of the tumors in the training set having <italic toggle="yes">A<sup>*</sup></italic> as the driver of <italic toggle="yes">E<sub>i</sub></italic>.</p><p hwp:id="p-39">Consider the following example. Let <italic toggle="yes">E<sub>PI3K</sub></italic> be a DEG in tumor <italic toggle="yes">t</italic>. Suppose the expression of <italic toggle="yes">E<sub>PI3K</sub></italic> is regulated by the PI3K pathway. Suppose also that <italic toggle="yes">PIK3CA</italic> is the most commonly perturbed member along that pathway (<xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-3" hwp:rel-id="F1">Figure 1</xref>), which leads it to be chosen as <italic toggle="yes">A<sup>*</sup></italic> according to the methods in <xref ref-type="sec" rid="s2a" hwp:id="xref-sec-3-1" hwp:rel-id="sec-3">Section 2.1</xref>. Current tumor <italic toggle="yes">t</italic> does not contain <italic toggle="yes">PIK3CA</italic> as an SGA, however. Thus, we need a causal explanation for DEG <italic toggle="yes">E<sub>PI3K</sub></italic> in tumor <italic toggle="yes">t</italic>. Suppose that <italic toggle="yes">PIK3R1</italic> is an SGA in tumor <italic toggle="yes">t</italic>. The method described below scores <italic toggle="yes">PIK3R1</italic> as a driver of <italic toggle="yes">E<sub>PI3K</sub></italic> for all the tumors in the training set that contain <italic toggle="yes">PIK3R1</italic> as an SGA; the remaining tumors in the training set are scored using <italic toggle="yes">PIK3CA</italic> as their driver; the overall score is a function of these two scores. This method is repeated for other SGAs in tumor <italic toggle="yes">t</italic> as candidate causes of <italic toggle="yes">E<sub>PI3K</sub></italic>. If <italic toggle="yes">PIK3R1</italic> turns out to be the SGA in tumor <italic toggle="yes">t</italic> that results in the highest overall score, then <italic toggle="yes">PIK3R1</italic> is output as the most likely driver of <italic toggle="yes">E<sub>PI3K</sub></italic> in tumor <italic toggle="yes">t</italic>. While this example illustrates the most basic situation in which tumor-specific scoring is called for, the general method can be useful in other circumstances as well.</p><p hwp:id="p-40">We now describe the mathematical method we used to implement tumor-specific scoring. In tumor <italic toggle="yes">t</italic>, we want to find the most probable cause of each <italic toggle="yes">E<sub>i</sub></italic> that has a value of 1 (i.e., is a DEG). Let <italic toggle="yes">A</italic><sub><italic toggle="yes">g</italic>(<italic toggle="yes">i</italic>)</sub> denote a hypothesized gene that is causing <italic toggle="yes">E<sub>i</sub></italic> to be a DEG in tumor t. In order for <italic toggle="yes">A</italic><sub><italic toggle="yes">g</italic>(<italic toggle="yes">i</italic>)</sub> to be a candidate cause, we require that it be altered (i.e., have a value of 1) in tumor <italic toggle="yes">t</italic>. Let <inline-formula hwp:id="inline-formula-3"><alternatives hwp:id="alternatives-15"><inline-graphic xlink:href="225631_inline3.gif" hwp:id="inline-graphic-3"/></alternatives></inline-formula> denote the set of tumors in the training set in which variable <italic toggle="yes">A</italic><sub><italic toggle="yes">g</italic>(<italic toggle="yes">i</italic>)</sub> has the value 1, which denotes that these tumors have somatic genome alteration (SGA) in gene <italic toggle="yes">A</italic><sub><italic toggle="yes">g</italic>(<italic toggle="yes">i</italic>)</sub>. We can calculate <inline-formula hwp:id="inline-formula-4"><alternatives hwp:id="alternatives-16"><inline-graphic xlink:href="225631_inline4.gif" hwp:id="inline-graphic-4"/></alternatives></inline-formula> with respect the tumor set <inline-formula hwp:id="inline-formula-5"><alternatives hwp:id="alternatives-17"><inline-graphic xlink:href="225631_inline5.gif" hwp:id="inline-graphic-5"/></alternatives></inline-formula> as follows:
<disp-formula id="eqn13" hwp:id="disp-formula-13" hwp:rev-id="xref-disp-formula-13-1">
<alternatives hwp:id="alternatives-18"><graphic xlink:href="225631_eqn13.gif" position="float" orientation="portrait" hwp:id="graphic-15"/></alternatives>
</disp-formula>
where <inline-formula hwp:id="inline-formula-6"><alternatives hwp:id="alternatives-19"><inline-graphic xlink:href="225631_inline6.gif" hwp:id="inline-graphic-6"/></alternatives></inline-formula> is the number of cases in <inline-formula hwp:id="inline-formula-7"><alternatives hwp:id="alternatives-20"><inline-graphic xlink:href="225631_inline7.gif" hwp:id="inline-graphic-7"/></alternatives></inline-formula> that node <italic toggle="yes">E<sub>i</sub></italic> has value <italic toggle="yes">k</italic> and its parent <italic toggle="yes">A</italic><sub><italic toggle="yes">g</italic>(<italic toggle="yes">i</italic>)</sub> has value <italic toggle="yes">j</italic>. Since <inline-formula hwp:id="inline-formula-8"><alternatives hwp:id="alternatives-21"><inline-graphic xlink:href="225631_inline8.gif" hwp:id="inline-graphic-8"/></alternatives></inline-formula> represents the tumors for which <italic toggle="yes">A</italic><sub><italic toggle="yes">g</italic>(<italic toggle="yes">i</italic>)</sub> has the value 1, this means that <italic toggle="yes">j</italic> is fixed at the value 1. Thus, we can simplify <xref ref-type="disp-formula" rid="eqn13" hwp:id="xref-disp-formula-13-1" hwp:rel-id="disp-formula-13">Equation 13</xref> to be the following:
<disp-formula id="eqn14" hwp:id="disp-formula-14" hwp:rev-id="xref-disp-formula-14-1">
<alternatives hwp:id="alternatives-22"><graphic xlink:href="225631_eqn14.gif" position="float" orientation="portrait" hwp:id="graphic-16"/></alternatives>
</disp-formula></p><p hwp:id="p-41">Let <inline-formula hwp:id="inline-formula-9"><alternatives hwp:id="alternatives-23"><inline-graphic xlink:href="225631_inline9.gif" hwp:id="inline-graphic-9"/></alternatives></inline-formula> denote the set of tumors in the training set in which variable <italic toggle="yes">A</italic><sub><italic toggle="yes">g</italic>(<italic toggle="yes">i</italic>)</sub> has the value 0, which represents that these tumors do not have genome alteration in <italic toggle="yes">A</italic><sub><italic toggle="yes">g</italic>(<italic toggle="yes">i</italic>)</sub>. We need to determine the most likely parent of <italic toggle="yes">E<sub>i</sub></italic> for these tumors. An efficient way to do so, which we use, is to find the most likely gene <italic toggle="yes">A<sup>*</sup></italic> that causes <italic toggle="yes">E<sub>i</sub></italic> over all tumors in dataset <italic toggle="yes">D</italic>. Then, we hypothesize that gene as the cause of <italic toggle="yes">E<sub>i</sub></italic> in <inline-formula hwp:id="inline-formula-10"><alternatives hwp:id="alternatives-24"><inline-graphic xlink:href="225631_inline10.gif" hwp:id="inline-graphic-10"/></alternatives></inline-formula>. This approach is efficient, because we only have to perform the search once for each <italic toggle="yes">E<sub>i</sub></italic> prior to seeing the current tumor <italic toggle="yes">t</italic>. More specifically, we use the <italic toggle="yes">f</italic> score from <xref ref-type="disp-formula" rid="eqn10" hwp:id="xref-disp-formula-10-1" hwp:rel-id="disp-formula-10">Equation 10</xref> (on the data <italic toggle="yes">D</italic> on all the tumors) to search over all possible genes to find the one that maximizes the score. Let <italic toggle="yes">A</italic><sub><italic toggle="yes">G</italic>(<italic toggle="yes">i</italic>)</sub> denote such a maximal scoring gene. We take <italic toggle="yes">A</italic><sub><italic toggle="yes">G</italic>(<italic toggle="yes">i</italic>)</sub> to be the parent of <italic toggle="yes">E<sub>i</sub></italic> for all the tumors in <inline-formula hwp:id="inline-formula-11"><alternatives hwp:id="alternatives-25"><inline-graphic xlink:href="225631_inline11.gif" hwp:id="inline-graphic-11"/></alternatives></inline-formula>. The score for this parent in these tumors in as follows:
<disp-formula id="eqn15" hwp:id="disp-formula-15" hwp:rev-id="xref-disp-formula-15-1">
<alternatives hwp:id="alternatives-26"><graphic xlink:href="225631_eqn15.gif" position="float" orientation="portrait" hwp:id="graphic-17"/></alternatives>
</disp-formula></p><p hwp:id="p-42">We arrive at a tumor-centric score <italic toggle="yes">e(g(i), i)</italic> by taking the product of <xref ref-type="disp-formula" rid="eqn14" hwp:id="xref-disp-formula-14-1" hwp:rel-id="disp-formula-14">Equation 14</xref> and <xref ref-type="disp-formula" rid="eqn15" hwp:id="xref-disp-formula-15-1" hwp:rel-id="disp-formula-15">Equation 15</xref>:
<disp-formula id="eqn16" hwp:id="disp-formula-16" hwp:rev-id="xref-disp-formula-16-1 xref-disp-formula-16-2">
<alternatives hwp:id="alternatives-27"><graphic xlink:href="225631_eqn16.gif" position="float" orientation="portrait" hwp:id="graphic-18"/></alternatives>
</disp-formula></p><p hwp:id="p-43">In tumor <italic toggle="yes">t</italic>, consider an <italic toggle="yes">E<sub>i</sub></italic> that is a DEG (i.e., <italic toggle="yes">E<sub>i</sub></italic> = 1). We search over all the genes that have a value of 1 (i.e., that are SGAs). For each such <italic toggle="yes">A</italic><sub><italic toggle="yes">g</italic>(<italic toggle="yes">i</italic>)</sub>, we use <xref ref-type="disp-formula" rid="eqn16" hwp:id="xref-disp-formula-16-1" hwp:rel-id="disp-formula-16">Equation 16</xref> to score it. The <italic toggle="yes">A</italic><sub><italic toggle="yes">g</italic>(<italic toggle="yes">i</italic>)</sub> that has the highest score is returned as the most likely cause of <italic toggle="yes">E<sub>i</sub></italic> in tumor <italic toggle="yes">t</italic>. We perform this procedure for each <italic toggle="yes">E<sub>i</sub></italic> that is a DEG in tumor <italic toggle="yes">t</italic>. After doing so, we have determined the most likely SGA causing each DEG in tumor <italic toggle="yes">t</italic>.</p></sec></sec><sec id="s3" hwp:id="sec-5"><label>3.</label><title hwp:id="title-8">Implementation Details</title><p hwp:id="p-44">The following shows the implementation details of our models, i.e., general method and tumor-centric method. Also, in order to apply the methods in the previous section, we need to specify both structure priors and parameter priors.</p><sec id="s3a" hwp:id="sec-6"><label>3.1.</label><title hwp:id="title-9">Pseudocode</title><p hwp:id="p-45">The TCI pseudocode in this section consists of a general method and a tumor-centric method. The general method is used to derive the most probable parent <italic toggle="yes">A</italic><sub><italic toggle="yes">G</italic>(<italic toggle="yes">i</italic>)</sub> for each node <italic toggle="yes">E<sub>i</sub></italic> across all tumors in training set <italic toggle="yes">D</italic>. Then, the tumor-centric method calculates the Bayesian causal score for each edge <italic toggle="yes">A<sub>h</sub></italic> → <italic toggle="yes">E<sub>i</sub></italic> in each tumor <italic toggle="yes">t</italic>.</p><sec id="s3a1" hwp:id="sec-7"><label>3.1.1</label><title hwp:id="title-10">General method</title><preformat position="float" orientation="portrait" xml:space="preserve" hwp:id="preformat-1">
var dataset <italic toggle="yes">D</italic>; set <bold>SGA’, DEG’</bold>; array <italic toggle="yes">cause</italic>; integer <italic toggle="yes">i, h, m’, n’</italic>; real <italic toggle="yes">d</italic>;
<bold>SGA’</bold> = the set of genes that have aberrant genome alterations in any tumor of <italic toggle="yes">D</italic>;
<italic toggle="yes">m’</italic> = |<bold>SGA’</bold>|
<bold>DEG’</bold> = the set of genes that are differentially expressed in any tumor of <italic toggle="yes">D</italic>;
<italic toggle="yes">n’</italic> = |<bold>DEG’</bold>|
for <italic toggle="yes">i</italic> = 1 to <italic toggle="yes">n’</italic> do // search for the global driver <italic toggle="yes">A</italic><sub><italic toggle="yes">G</italic>(<italic toggle="yes">i</italic>)</sub> for each <italic toggle="yes">E<sub>i</sub></italic> at the population level
        for <italic toggle="yes">h</italic> = 0 to <italic toggle="yes">m’</italic> do
                <italic toggle="yes">compute f</italic>(<italic toggle="yes">h, i</italic>); //use <xref ref-type="disp-formula" rid="eqn10" hwp:id="xref-disp-formula-10-2" hwp:rel-id="disp-formula-10">Equation 10</xref> to compute <italic toggle="yes">f</italic>(<italic toggle="yes">h, i</italic>)
        <italic toggle="yes">A</italic><sub><italic toggle="yes">G</italic>(<italic toggle="yes">i</italic>)</sub> is identified as the SGA <italic toggle="yes">G</italic>(<italic toggle="yes">i</italic>) that has the highest <italic toggle="yes">f</italic>(<italic toggle="yes">h, i</italic>) for <italic toggle="yes">E<sub>i</sub></italic>.
</preformat></sec><sec id="s3a2" hwp:id="sec-8"><label>3.1.2</label><title hwp:id="title-11">Tumor-centric causal inference</title><preformat position="float" orientation="portrait" xml:space="preserve" hwp:id="preformat-2">
var dataset <italic toggle="yes">D</italic>; set <bold>SGA, DEG</bold>; array <italic toggle="yes">cause</italic>; integer <italic toggle="yes">i, h, m, n</italic>; real <italic toggle="yes">d</italic>;
<bold>SGA</bold> = the set of genes in tumor <italic toggle="yes">t</italic> that have aberrant genome alterations;
<italic toggle="yes">m</italic> = |<bold>SGA</bold>|
<bold>DEG</bold> = the set of genes in tumor <italic toggle="yes">t</italic> that are differentially expressed;
<italic toggle="yes">n</italic> = |<bold>DEG</bold>|
for <italic toggle="yes">i</italic> = 1 to <italic toggle="yes">n</italic> do //populate the values of the <italic toggle="yes">cause</italic> array
        <italic toggle="yes">d</italic> = 0,
        for <italic toggle="yes">h</italic> = 0 to <italic toggle="yes">m</italic> do
                use the global driver <italic toggle="yes">A</italic><sub><italic toggle="yes">G</italic>(<italic toggle="yes">i</italic>)</sub> for <italic toggle="yes">E<sub>i</sub></italic> as determined using the general method;
                <italic toggle="yes">d</italic> := <italic toggle="yes">d</italic> + <italic toggle="yes">e</italic>(<italic toggle="yes">h, i</italic>); //use <xref ref-type="disp-formula" rid="eqn16" hwp:id="xref-disp-formula-16-2" hwp:rel-id="disp-formula-16">Equation 16</xref> to compute <italic toggle="yes">e</italic>(<italic toggle="yes">h, i</italic>)
        for <italic toggle="yes">h</italic> = 0 to <italic toggle="yes">m</italic> do
                <italic toggle="yes">cause</italic> [<italic toggle="yes">h, i</italic>] := <italic toggle="yes">e</italic>(<italic toggle="yes">h, i</italic>)/<italic toggle="yes">d</italic>;
</preformat></sec></sec><sec id="s3b" hwp:id="sec-9"><label>3.2.</label><title hwp:id="title-12">Structure priors</title><p hwp:id="p-46">Given the tumor of interest with a unique <bold>SGA</bold> set and a unique <bold>DEG</bold> set, we need to define a tumor specific structure prior <italic toggle="yes">P</italic>(<italic toggle="yes">M</italic>) over permissible CBN structures <italic toggle="yes">M</italic>. Because the <bold>SGA</bold> and <bold>DEG</bold> sets are (with high probability) unique to each tumor, the prior distribution over <italic toggle="yes">M</italic> is also tumor-specific. Assuming the structure prior is modular, we can factorize the <italic toggle="yes">P</italic>(<italic toggle="yes">M</italic>) as a product of prior probabilities for each permissible edge as follows:
<disp-formula id="eqn17" hwp:id="disp-formula-17">
<alternatives hwp:id="alternatives-28"><graphic xlink:href="225631_eqn17.gif" position="float" orientation="portrait" hwp:id="graphic-19"/></alternatives>
</disp-formula></p><p hwp:id="p-47"><italic toggle="yes">P</italic>(<italic toggle="yes">M</italic>) comprises a product of prior probabilities of causal edges of a test. A prior probability of a causal edge from a somatic alteration of gene <italic toggle="yes">A<sub>h</sub></italic> to a DEG <italic toggle="yes">E<sub>i</sub></italic> can be stated as <italic toggle="yes">P</italic>(<italic toggle="yes">A<sub>h</sub></italic> → <italic toggle="yes">E<sub>i</sub></italic>) (abbreviated as <italic toggle="yes">θ<sub>h</sub></italic>) and determined according to:
<disp-formula id="eqn18" hwp:id="disp-formula-18">
<alternatives hwp:id="alternatives-29"><graphic xlink:href="225631_eqn18.gif" position="float" orientation="portrait" hwp:id="graphic-20"/></alternatives>
</disp-formula>
where <italic toggle="yes">θ</italic><sub>0</sub> is a prior probability that the cause of DEG <italic toggle="yes">E<sub>i</sub></italic> is not an SGA, and <italic toggle="yes">h’</italic> indexes over the number <italic toggle="yes">m</italic> of genes in tumor <italic toggle="yes">t</italic> that have SGAs.</p><p hwp:id="p-48">Additional genomic information can be applied to derive the prior probability of each edge <italic toggle="yes">A<sub>h</sub></italic> → <italic toggle="yes">E<sub>i</sub></italic> using existing prior knowledge. Consider, for example, the availability of the following information for each gene <italic toggle="yes">h</italic>: (1) the number of unique synonymous mutations observed for <italic toggle="yes">h</italic> among the tumors in <italic toggle="yes">D</italic>, and (2) the number of abnormal somatic copy number alterations (according to a given definition of abnormal) of <italic toggle="yes">h</italic> in a normal population without cancer. Such information can be applied to help account for mutation and copy number alterations that are due to differences in gene lengths and chromosome locations. In particular, using the information in (1) and (2) above, we can calculate <italic toggle="yes">μ<sub>h</sub></italic> as follows:
<disp-formula id="eqn19" hwp:id="disp-formula-19">
<alternatives hwp:id="alternatives-30"><graphic xlink:href="225631_eqn19.gif" position="float" orientation="portrait" hwp:id="graphic-21"/></alternatives>
</disp-formula>
where <italic toggle="yes">U<sub>h</sub></italic> denotes the tumors in training set <italic toggle="yes">D</italic> that have a somatic alteration in gene <italic toggle="yes">A<sub>h</sub></italic>, and <italic toggle="yes">w<sub>ht’</sub></italic> denotes a weight proportional to the probability that SGA <italic toggle="yes">h</italic> is a driver in the genome of tumor <italic toggle="yes">t’</italic>. We calculate <italic toggle="yes">w<sub>ht’</sub></italic> as follows:
<disp-formula id="eqn20" hwp:id="disp-formula-20">
<alternatives hwp:id="alternatives-31"><graphic xlink:href="225631_eqn20.gif" position="float" orientation="portrait" hwp:id="graphic-22"/></alternatives>
</disp-formula>
where
<disp-formula id="eqn21" hwp:id="disp-formula-21" hwp:rev-id="xref-disp-formula-21-1">
<alternatives hwp:id="alternatives-32"><graphic xlink:href="225631_eqn21.gif" position="float" orientation="portrait" hwp:id="graphic-23"/></alternatives>
</disp-formula></p><p hwp:id="p-49">In <xref ref-type="disp-formula" rid="eqn21" hwp:id="xref-disp-formula-21-1" hwp:rel-id="disp-formula-21">equation 21</xref>, <inline-formula hwp:id="inline-formula-12"><alternatives hwp:id="alternatives-33"><inline-graphic xlink:href="225631_inline12.gif" hwp:id="inline-graphic-12"/></alternatives></inline-formula> denotes whether gene <italic toggle="yes">h</italic> has a non-synonymous somatic mutation (SM) event or not in tumor <italic toggle="yes">t’</italic>, i.e., 1 or 0, respectively; <inline-formula hwp:id="inline-formula-13"><alternatives hwp:id="alternatives-34"><inline-graphic xlink:href="225631_inline13.gif" hwp:id="inline-graphic-13"/></alternatives></inline-formula> denotes the number of unique synonymous mutation events in gene <italic toggle="yes">h</italic> observed in the reference set of tumor genomes, <italic toggle="yes">D</italic>; <inline-formula hwp:id="inline-formula-14"><alternatives hwp:id="alternatives-35"><inline-graphic xlink:href="225631_inline14.gif" hwp:id="inline-graphic-14"/></alternatives></inline-formula> denotes whether gene <italic toggle="yes">h</italic> is affected by an SCNA event or not in tumor <italic toggle="yes">t’</italic>, i.e., 1 or 0, respectively; <inline-formula hwp:id="inline-formula-15"><alternatives hwp:id="alternatives-36"><inline-graphic xlink:href="225631_inline15.gif" hwp:id="inline-graphic-15"/></alternatives></inline-formula> denotes the expected number of times gene <italic toggle="yes">h</italic> is affected by copy number alteration among the tumors in <italic toggle="yes">D</italic>, and yet is only a passenger alteration, based on the number of times gene <italic toggle="yes">h</italic> is affected by copy number alteration in a reference set of cases from a normal human population without known cancer.</p></sec><sec id="s3c" hwp:id="sec-10"><label>3.3.</label><title hwp:id="title-13">Parameter priors</title><p hwp:id="p-50">We need parameter priors for when <italic toggle="yes">E<sub>i</sub></italic> has <italic toggle="yes">A<sub>0</sub></italic> as its parent and for when it has an <italic toggle="yes">A<sub>h</sub></italic> in <bold>SGA</bold> set as its parent. <xref ref-type="table" rid="tbl1" hwp:id="xref-table-wrap-1-1" hwp:rel-id="T1">Table 1</xref> addresses the case when <italic toggle="yes">E<sub>i</sub></italic> has <italic toggle="yes">A<sub>0</sub></italic> as its parent. The Dirichlet parameter values in the table represent that every probability of <italic toggle="yes">P</italic>(<italic toggle="yes">E<sub>i</sub></italic> = 1) is equally likely a <italic toggle="yes">priori</italic> (i.e., before any data are considered); recall that <italic toggle="yes">E<sub>i</sub></italic> = 1 represents that <italic toggle="yes">E<sub>i</sub></italic> is abnormal. <xref ref-type="table" rid="tbl2" hwp:id="xref-table-wrap-2-1" hwp:rel-id="T2">Table 2</xref> addresses the case in which <italic toggle="yes">E<sub>i</sub></italic> has some parent <italic toggle="yes">A<sub>h</sub></italic>. The Dirichlet parameter values in the table make it somewhat more likely that <italic toggle="yes">E<sub>i</sub></italic> will be normal (abnormal) when its cause <italic toggle="yes">A<sub>h</sub></italic> is normal (abnormal). To make that pattern stronger, the values of 2.0 could be replaced with larger values, such as 2.5, 3.0, or even higher.</p><table-wrap id="tbl1" orientation="portrait" position="float" hwp:id="T1" hwp:rev-id="xref-table-wrap-1-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;225631v1/TBL1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T1</object-id><object-id pub-id-type="publisher-id">tbl1</object-id><label>Table 1.</label><caption hwp:id="caption-3"><title hwp:id="title-14">Dirichlet parameter values when <italic toggle="yes">A<sub>0</sub></italic> is the parent of node <italic toggle="yes">E<sub>i</sub></italic>.</title></caption><graphic xlink:href="225631_tbl1" position="float" orientation="portrait" hwp:id="graphic-24"/></table-wrap><table-wrap id="tbl2" orientation="portrait" position="float" hwp:id="T2" hwp:rev-id="xref-table-wrap-2-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;225631v1/TBL2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T2</object-id><object-id pub-id-type="publisher-id">tbl2</object-id><label>Table 2.</label><caption hwp:id="caption-4"><title hwp:id="title-15">Dirichlet parameter values when there is one <italic toggle="yes">A<sub>h</sub></italic> parent of node <italic toggle="yes">E<sub>i</sub></italic>.</title></caption><graphic xlink:href="225631_tbl2" position="float" orientation="portrait" hwp:id="graphic-25"/></table-wrap><p hwp:id="p-51">The computations in this paper have used standard arithmetic operations. However, model scores can become extremely small. Therefore, it is generally necessary to use log arithmetic. When doing so, <xref ref-type="disp-formula" rid="eqn7" hwp:id="xref-disp-formula-7-2" hwp:rel-id="disp-formula-7">Equation 7</xref>, for example, becomes a sum of log terms, rather than a product of terms.</p></sec></sec></body><back><ref-list hwp:id="ref-list-1"><title hwp:id="title-16">References</title><ref id="c1" hwp:id="ref-1" hwp:rev-id="xref-ref-1-1 xref-ref-1-2"><label>1.</label><citation publication-type="journal" citation-type="journal" ref:id="225631v1.1" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-1"><string-name name-style="western" hwp:sortable="Lawrence MS"><surname>Lawrence</surname> <given-names>MS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Stojanov P"><surname>Stojanov</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Polak P"><surname>Polak</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kryukov GV"><surname>Kryukov</surname> <given-names>GV</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cibulskis K"><surname>Cibulskis</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sivachenko A"><surname>Sivachenko</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Carter SL"><surname>Carter</surname> <given-names>SL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Stewart C"><surname>Stewart</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mermel CH"><surname>Mermel</surname> <given-names>CH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Roberts SA"><surname>Roberts</surname> <given-names>SA</given-names></string-name> <etal>et al</etal>: <article-title hwp:id="article-title-2">Mutational heterogeneity in cancer and the search for new cancer-associated genes</article-title>. <source hwp:id="source-1">Nature</source> <year>2013</year>, <volume>499</volume>(<issue>7457</issue>):<fpage>214</fpage>–<lpage>218</lpage>.</citation></ref><ref id="c2" hwp:id="ref-2"><label>2.</label><citation publication-type="journal" citation-type="journal" ref:id="225631v1.2" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-2"><string-name name-style="western" hwp:sortable="Gonzalez-Perez A"><surname>Gonzalez-Perez</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Deu-Pons J"><surname>Deu-Pons</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lopez-Bigas N"><surname>Lopez-Bigas</surname> <given-names>N</given-names></string-name>: <article-title hwp:id="article-title-3">Improving the prediction of the functional impact of cancer mutations by baseline tolerance transformation</article-title>. <source hwp:id="source-2">Genome Med</source> <year>2012</year>, <volume>4</volume>(<issue>11</issue>):<fpage>89</fpage>.</citation></ref><ref id="c3" hwp:id="ref-3" hwp:rev-id="xref-ref-3-1 xref-ref-3-2"><label>3.</label><citation publication-type="journal" citation-type="journal" ref:id="225631v1.3" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-3"><string-name name-style="western" hwp:sortable="Kandoth C"><surname>Kandoth</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="McLellan MD"><surname>McLellan</surname> <given-names>MD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Vandin F"><surname>Vandin</surname> <given-names>F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ye K"><surname>Ye</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Niu B"><surname>Niu</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lu C"><surname>Lu</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Xie M"><surname>Xie</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhang Q"><surname>Zhang</surname> <given-names>Q</given-names></string-name>, <string-name name-style="western" hwp:sortable="McMichael JF"><surname>McMichael</surname> <given-names>JF</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wyczalkowski MA"><surname>Wyczalkowski</surname> <given-names>MA</given-names></string-name> <etal>et al</etal>: <article-title hwp:id="article-title-4">Mutational landscape and significance across 12 major cancer types</article-title>. <source hwp:id="source-3">Nature</source> <year>2013</year>, <volume>502</volume>(<issue>7471</issue>):<fpage>333</fpage>–<lpage>339</lpage>.</citation></ref><ref id="c4" hwp:id="ref-4" hwp:rev-id="xref-ref-4-1"><label>4.</label><citation publication-type="journal" citation-type="journal" ref:id="225631v1.4" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-4"><string-name name-style="western" hwp:sortable="Dees ND"><surname>Dees</surname> <given-names>ND</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhang Q"><surname>Zhang</surname> <given-names>Q</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kandoth C"><surname>Kandoth</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wendl MC"><surname>Wendl</surname> <given-names>MC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schierding W"><surname>Schierding</surname> <given-names>W</given-names></string-name>, <string-name name-style="western" hwp:sortable="Koboldt DC"><surname>Koboldt</surname> <given-names>DC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mooney TB"><surname>Mooney</surname> <given-names>TB</given-names></string-name>, <string-name name-style="western" hwp:sortable="Callaway MB"><surname>Callaway</surname> <given-names>MB</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dooling D"><surname>Dooling</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mardis ER"><surname>Mardis</surname> <given-names>ER</given-names></string-name> <etal>et al</etal>: <article-title hwp:id="article-title-5">MuSiC: identifying mutational significance in cancer genomes</article-title>. <source hwp:id="source-4">Genome Res</source> <year>2012</year>, <volume>22</volume>(<issue>8</issue>):<fpage>1589</fpage>–<lpage>1598</lpage>.</citation></ref><ref id="c5" hwp:id="ref-5" hwp:rev-id="xref-ref-5-1"><label>5.</label><citation publication-type="journal" citation-type="journal" ref:id="225631v1.5" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-5"><string-name name-style="western" hwp:sortable="Ciriello G"><surname>Ciriello</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Miller ML"><surname>Miller</surname> <given-names>ML</given-names></string-name>, <string-name name-style="western" hwp:sortable="Aksoy BA"><surname>Aksoy</surname> <given-names>BA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Senbabaoglu Y"><surname>Senbabaoglu</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schultz N"><surname>Schultz</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sander C"><surname>Sander</surname> <given-names>C</given-names></string-name>: <article-title hwp:id="article-title-6">Emerging landscape of oncogenic signatures across human cancers</article-title>. <source hwp:id="source-5">Nat Genet</source> <year>2013</year>, <volume>45</volume>(<issue>10</issue>):<fpage>1127</fpage>–<lpage>1133</lpage>.</citation></ref><ref id="c6" hwp:id="ref-6"><label>6.</label><citation publication-type="journal" citation-type="journal" ref:id="225631v1.6" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-6"><string-name name-style="western" hwp:sortable="Stransky N"><surname>Stransky</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cerami E"><surname>Cerami</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schalm S"><surname>Schalm</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kim JL"><surname>Kim</surname> <given-names>JL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lengauer C"><surname>Lengauer</surname> <given-names>C</given-names></string-name>: <article-title hwp:id="article-title-7">The landscape of kinase fusions in cancer</article-title>. <source hwp:id="source-6">Nat Commun</source> <year>2014</year>, <volume>5</volume>:<fpage>4846</fpage>.</citation></ref><ref id="c7" hwp:id="ref-7" hwp:rev-id="xref-ref-7-1"><label>7.</label><citation publication-type="journal" citation-type="journal" ref:id="225631v1.7" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-7"><string-name name-style="western" hwp:sortable="Dawson MA"><surname>Dawson</surname> <given-names>MA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kouzarides T"><surname>Kouzarides</surname> <given-names>T</given-names></string-name>: <article-title hwp:id="article-title-8">Cancer epigenetics: from mechanism to therapy</article-title>. <source hwp:id="source-7">Cell</source> <year>2012</year>, <volume>150</volume>(<issue>1</issue>):<fpage>12</fpage>–<lpage>27</lpage>.</citation></ref><ref id="c8" hwp:id="ref-8" hwp:rev-id="xref-ref-8-1"><label>8.</label><citation publication-type="journal" citation-type="journal" ref:id="225631v1.8" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-8"><string-name name-style="western" hwp:sortable="Heidenreich B"><surname>Heidenreich</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rachakonda PS"><surname>Rachakonda</surname> <given-names>PS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hemminki K"><surname>Hemminki</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kumar R"><surname>Kumar</surname> <given-names>R</given-names></string-name>: <article-title hwp:id="article-title-9">TERT promoter mutations in cancer development</article-title>. <source hwp:id="source-8">Curr Opin Genet Dev</source> <year>2014</year>, <volume>24</volume>:<fpage>30</fpage>–<lpage>37</lpage>.</citation></ref><ref id="c9" hwp:id="ref-9" hwp:rev-id="xref-ref-9-1"><label>9.</label><citation publication-type="journal" citation-type="journal" ref:id="225631v1.9" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-9"><string-name name-style="western" hwp:sortable="Xie H"><surname>Xie</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Liu T"><surname>Liu</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wang N"><surname>Wang</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bjornhagen V"><surname>Bjornhagen</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hoog A"><surname>Hoog</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Larsson C"><surname>Larsson</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lui WO"><surname>Lui</surname> <given-names>WO</given-names></string-name>, <string-name name-style="western" hwp:sortable="Xu D"><surname>Xu</surname> <given-names>D</given-names></string-name>: <article-title hwp:id="article-title-10">TERT promoter mutations and gene amplification: promoting TERT expression in Merkel cell carcinoma</article-title>. <source hwp:id="source-9">Oncotarget</source> <year>2014</year>, <volume>5</volume>(<issue>20</issue>):<fpage>10048</fpage>–<lpage>10057</lpage>.</citation></ref><ref id="c10" hwp:id="ref-10" hwp:rev-id="xref-ref-10-1"><label>10.</label><citation publication-type="book" citation-type="book" ref:id="225631v1.10" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-10"><string-name name-style="western" hwp:sortable="Pearl J"><surname>Pearl</surname> <given-names>J</given-names></string-name>: <chapter-title>Causality: Models, Reasoning and Inference</chapter-title>, <edition>2nd</edition> edn: <publisher-name>Cambridge University Press</publisher-name>; <year>2009</year>.</citation></ref><ref id="c11" hwp:id="ref-11" hwp:rev-id="xref-ref-11-1"><label>11.</label><citation publication-type="book" citation-type="book" ref:id="225631v1.11" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-11"><string-name name-style="western" hwp:sortable="Glymour C"><surname>Glymour</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cooper G"><surname>Cooper</surname> <given-names>G</given-names></string-name>: <chapter-title>Computation, Causation, and Discovery</chapter-title>. <publisher-loc>Cambridge, MA</publisher-loc>: <publisher-name>MIT Press</publisher-name>; <year>1999</year>.</citation></ref><ref id="c12" hwp:id="ref-12" hwp:rev-id="xref-ref-12-1"><label>12.</label><citation publication-type="journal" citation-type="journal" ref:id="225631v1.12" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-12"><string-name name-style="western" hwp:sortable="Boyle EA"><surname>Boyle</surname> <given-names>EA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Li YI"><surname>Li</surname> <given-names>YI</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pritchard JK"><surname>Pritchard</surname> <given-names>JK</given-names></string-name>: <article-title hwp:id="article-title-11">An Expanded View of Complex Traits: From Polygenic to Omnigenic</article-title>. <source hwp:id="source-10">Cell</source> <year>2017</year>, <volume>169</volume>(<issue>7</issue>):<fpage>1177</fpage>–<lpage>1186</lpage>.</citation></ref><ref id="c13" hwp:id="ref-13" hwp:rev-id="xref-ref-13-1"><label>13.</label><citation publication-type="journal" citation-type="journal" ref:id="225631v1.13" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-13"><string-name name-style="western" hwp:sortable="Nica AC"><surname>Nica</surname> <given-names>AC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dermitzakis ET"><surname>Dermitzakis</surname> <given-names>ET</given-names></string-name>: <article-title hwp:id="article-title-12">Expression quantitative trait loci: present and future</article-title>. <source hwp:id="source-11">Philos Trans R Soc Lond B Biol Sci</source> <year>2013</year>, <volume>368</volume>(<issue>1620</issue>):<fpage>20120362</fpage>.</citation></ref><ref id="c14" hwp:id="ref-14" hwp:rev-id="xref-ref-14-1 xref-ref-14-2"><label>14.</label><citation publication-type="journal" citation-type="journal" ref:id="225631v1.14" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-14"><string-name name-style="western" hwp:sortable="Cully M"><surname>Cully</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="You H"><surname>You</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Levine AJ"><surname>Levine</surname> <given-names>AJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mak TW"><surname>Mak</surname> <given-names>TW</given-names></string-name>: <article-title hwp:id="article-title-13">Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis</article-title>. <source hwp:id="source-12">Nat Rev Cancer</source> <year>2006</year>, <volume>6</volume>(<issue>3</issue>):<fpage>184</fpage>–<lpage>192</lpage>.</citation></ref><ref id="c15" hwp:id="ref-15" hwp:rev-id="xref-ref-15-1"><label>15.</label><citation publication-type="journal" citation-type="journal" ref:id="225631v1.15" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-15"><string-name name-style="western" hwp:sortable="Lu S"><surname>Lu</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lu KN"><surname>Lu</surname> <given-names>KN</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cheng SY"><surname>Cheng</surname> <given-names>SY</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hu B"><surname>Hu</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ma X"><surname>Ma</surname> <given-names>X</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nystrom N"><surname>Nystrom</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lu X"><surname>Lu</surname> <given-names>X</given-names></string-name>: <article-title hwp:id="article-title-14">Identifying Driver Genomic Alterations in Cancers by Searching Minimum-Weight, Mutually Exclusive Sets</article-title>. <source hwp:id="source-13">PLoS Comput Biol</source> <year>2015</year>, <volume>11</volume>(<issue>8</issue>):<fpage>e1004257</fpage>.</citation></ref><ref id="c16" hwp:id="ref-16"><label>16.</label><citation publication-type="journal" citation-type="journal" ref:id="225631v1.16" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-16"><collab hwp:id="collab-1">Cancer Genome Atlas Research N</collab>: <article-title hwp:id="article-title-15">Comprehensive genomic characterization defines human glioblastoma genes and core pathways</article-title>. <source hwp:id="source-14">Nature</source> <year>2008</year>, <volume>455</volume>(<issue>7216</issue>):<fpage>1061</fpage>–<lpage>1068</lpage>.</citation></ref><ref id="c17" hwp:id="ref-17"><label>17.</label><citation publication-type="journal" citation-type="journal" ref:id="225631v1.17" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-17"><string-name name-style="western" hwp:sortable="Ciriello G"><surname>Ciriello</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cerami E"><surname>Cerami</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sander C"><surname>Sander</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schultz N"><surname>Schultz</surname> <given-names>N</given-names></string-name>: <article-title hwp:id="article-title-16">Mutual exclusivity analysis identifies oncogenic network modules</article-title>. <source hwp:id="source-15">Genome Res</source> <year>2012</year>, <volume>22</volume>(<issue>2</issue>):<fpage>398</fpage>–<lpage>406</lpage>.</citation></ref><ref id="c18" hwp:id="ref-18"><label>18.</label><citation publication-type="journal" citation-type="journal" ref:id="225631v1.18" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-18"><string-name name-style="western" hwp:sortable="Yamamoto H"><surname>Yamamoto</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Shigematsu H"><surname>Shigematsu</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nomura M"><surname>Nomura</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lockwood WW"><surname>Lockwood</surname> <given-names>WW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sato M"><surname>Sato</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Okumura N"><surname>Okumura</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Soh J"><surname>Soh</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Suzuki M"><surname>Suzuki</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wistuba II"><surname>Wistuba</surname>, <given-names>II</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fong KM"><surname>Fong</surname> <given-names>KM</given-names></string-name> <etal>et al</etal>: <article-title hwp:id="article-title-17">PIK3CA mutations and copy number gains in human lung cancers</article-title>. <source hwp:id="source-16">Cancer Res</source> <year>2008</year>, <volume>68</volume>(<issue>17</issue>):<fpage>6913</fpage>–<lpage>6921</lpage>.</citation></ref><ref id="c19" hwp:id="ref-19" hwp:rev-id="xref-ref-19-1"><label>19.</label><citation publication-type="journal" citation-type="journal" ref:id="225631v1.19" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-19"><string-name name-style="western" hwp:sortable="Vandin F"><surname>Vandin</surname> <given-names>F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Upfal E"><surname>Upfal</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Raphael BJ"><surname>Raphael</surname> <given-names>BJ</given-names></string-name>: <article-title hwp:id="article-title-18">De novo discovery of mutated driver pathways in cancer</article-title>. <source hwp:id="source-17">Genome Res</source> <year>2012</year>, <volume>22</volume>(<issue>2</issue>):<fpage>375</fpage>–<lpage>385</lpage>.</citation></ref><ref id="c20" hwp:id="ref-20" hwp:rev-id="xref-ref-20-1"><label>20.</label><citation publication-type="journal" citation-type="journal" ref:id="225631v1.20" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-20"><string-name name-style="western" hwp:sortable="Heckerman D"><surname>Heckerman</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Geiger D"><surname>Geiger</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chickering DM"><surname>Chickering</surname> <given-names>DM</given-names></string-name>: <article-title hwp:id="article-title-19">Learning bayesian networks: The combination of knowledge and statistical data</article-title>. <source hwp:id="source-18">Machine learning</source> <year>1995</year>, <volume>20</volume>(<issue>3</issue>):<fpage>197</fpage>–<lpage>243</lpage>.</citation></ref></ref-list></back></article>
